Biotech

Regeneron: REGN Stock Takes Out All the Stops

After already rallying for a few days, REGN stock on Tuesday shifted into a new gear and broke out to new all-time highs. What's next for Regeneron? More 

Trade of the Day: Stemline Therapeutics (STML)

Technicals can certainly give insight into big-name stocks–but they really shine in finding the best stocks to buy that might not have crossed your radar. More 

Among Biotechs, Amgen Stock Offers Dividend Income

Biotech giant AMGN has a nice benefit Amgen stock in that it pays a dividend. With a low payout ratio, investors should look for increases in the future. More 

Healthcare Stocks: No Longer a Sure Thing

Healthcare stocks have outperformed in recent years, but investors need to be selective with valuations that now are at richer levels. More 

AMGN: Amgen Stock Future Looks Bright for Investors

Amgen released earnings that put a smile on investor's faces, and Amgen stock looks like a solid buy for the long term More 

3 Biotechs to Buy and 1 to Sell Now

Biotechs are a sector where the whisper of FDA approval can send stocks soaring or falling. Here are 4 biotech stocks to watch for 2014, including 3 buys More 

3 Biotech Stocks Where Momentum is Alive and Well

If you are looking around the biotech space for the next knockout winner, take a look at these 3 contenders for the next big runup. More